Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinics of Perinatology

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clp.2015.08.010PMID 26593082PMCID PMC5863545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.

  2015cited by this paper
• Pulmonary hypertension in bronchopulmonary dysplasia: Clinical findings, cardiovascular anomalies and outcomes

  2014cited by this paper
• Pulmonary hypertension in preterm infants: prevalence and association with bronchopulmonary dysplasia.

  2014cited by this paper
• Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.

  2013cited by this paper
• Health-care utilization and respiratory morbidities in preterm infants with pulmonary hypertension

  2013cited by this paper
• Right Ventricular Systolic Dysfunction in Young Adults Born Preterm

  2013cited by this paper
• Histologic evidence of intrapulmonary anastomoses by three-dimensional reconstruction in severe bronchopulmonary dysplasia.

  2013cited by this paper
• Pulmonary arterial hypertension: MR imaging-derived first-pass bolus kinetic parameters are biomarkers for pulmonary hemodynamics, cardiac function, and ventricular remodeling.

  2012cited by this paper
• National Heart, Lung, and Blood Institute Workshop: Improving Outcomes for Pulmonary Vascular Disease

  2012cited by this paper
• Inhaled Nitric Oxide in Preterm Infants Undergoing Mechanical Ventilation

  2012cited by this paper
• eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.

  2012cited by this paper
• Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?

  2012cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension

  2012cited by this paper
• Prospective Analysis of Pulmonary Hypertension in Extremely Low Birth Weight Infants

  2012cited by this paper
• Fetal Growth Restriction and Pulmonary Hypertension in Premature Infants with Bronchopulmonary Dysplasia

  2012cited by this paper
• Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia.

  2012cited by this paper
• Persistently Elevated Right Ventricular Index of Myocardial Performance in Preterm Infants with Incipient Bronchopulmonary Dysplasia

  2012cited by this paper
• Assessment of pulmonary hypertension what CT and MRI can provide.

  2011cited by this paper
• Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice.

  2011cited by this paper
• Risk Factors for Pulmonary Artery Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia

  2011cited by this paper
• Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation

  2011cited by this paper
• Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep.

  2011cited by this paper
• Repeated bedside echocardiography in children with respiratory failure

  2011cited by this paper
• Angiogenesis-related gene expression profiling in ventilated preterm human lungs

  2010cited by this paper
• Developmental regulation of oxygen sensing and ion channels in the pulmonary vasculature.

  2010cited by this paper
• Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network

  2010cited by this paper
• Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia

  2010cited by this paper
• The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application.

  2010cited by this paper
• Maternal preeclampsia predicts the development of bronchopulmonary dysplasia.

  2010cited by this paper
• Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease.

  2010cited by this paper
• Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease.

  2009cited by this paper
• Pulmonary hypertension in bronchopulmonary dysplasia.

  2009cited by this paper
• Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.

  2009cited by this paper
• Endostatin Concentration in Cord Plasma Predicts the Development of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants

  2009cited by this paper
• Dysregulation of anti-angiogenic agents ( sFlt-1 , PLGF , and sEndoglin ) in preeclampsia — a step forward but not the definitive answer

  2009cited by this paper
• Myocardial tissue Doppler changes in patients with bronchopulmonary dysplasia.

  2008cited by this paper
• Chronic lung disease after premature birth.

  2008cited by this paper
• Left ventricular diastolic dysfunction in bronchopulmonary dysplasia.

  2008cited by this paper
• Clinical Utility of Echocardiography for the Diagnosis and Management of Pulmonary Vascular Disease in Young Children With Chronic Lung Disease

  2008cited by this paper
• Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia

  2008cited by this paper
• Pulmonary Vein Stenosis: Prematurity and Associated Conditions

  2008cited by this paper
• The dysmorphic pulmonary circulation in bronchopulmonary dysplasia: a growing story.

  2008cited by this paper
• Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease.

  2007cited by this paper
• Pulmonary Artery Hypertension in Formerly Premature Infants With Bronchopulmonary Dysplasia: Clinical Features and Outcomes in the Surfactant Era

  2007cited by this paper
• Quantitative 3D pulmonary MR-perfusion in patients with pulmonary arterial hypertension: correlation with invasive pressure measurements.

  2007cited by this paper
• Role of reactive oxygen species in chronic hypoxia-induced pulmonary hypertension and vascular remodeling.

  2007cited by this paper
• Chronic lung disease after premature birth.

  2007cited by this paper
• Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension

  2007cited by this paper
• Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.

  2006cited by this paper
• Growth of pulmonary microvasculature in ventilated preterm infants.

  2006cited by this paper
• Familial and Genetic Susceptibility to Major Neonatal Morbidities in Preterm Twins

  2006cited by this paper
• Early inhaled nitric oxide therapy in premature newborns with respiratory failure.

  2006cited by this paper
• Birth defects research part A - Clinical and molecular teratology

  2006cited by this paper
• The genetics of bronchopulmonary dysplasia.

  2006cited by this paper
• [Bronchopulmonary dysplasia].

  2005cited by this paper
• Noninvasive assessment and monitoring of the pulmonary circulation

  2005cited by this paper
• Vascular Endothelial Growth Factor Gene Therapy Increases Survival, Promotes Lung Angiogenesis, and Prevents Alveolar Damage in Hyperoxia-Induced Lung Injury: Evidence That Angiogenesis Participates in Alveolarization

  2005cited by this paper
• Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002.

  2005cited by this paper
• Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia.

  2004cited by this paper
• Growth factors in the fetal and neonatal lung.

  2004cited by this paper
• Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia.

  2004cited by this paper
• Pathology of new bronchopulmonary dysplasia.

  2003cited by this paper
• Statement on the care of the child with chronic lung disease of infancy and childhood.

  2003cited by this paper
• Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension.

  2003cited by this paper
• Safety, Reliability, and Validity of a Physiologic Definition of Bronchopulmonary Dysplasia

  2003cited by this paper
• Inhaled nitric oxide in premature infants with the respiratory distress syndrome.

  2003cited by this paper
• Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms.

  2002cited by this paper
• An unknown: lung growth and development after very preterm birth.

  2002cited by this paper
• The role of vascular growth factors in hyperoxia-induced injury to the developing lung.

  2002cited by this paper
• Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons.

  2002cited by this paper
• Bronchopulmonary dysplasia: "a vascular hypothesis".

  2001cited by this paper
• Bronchopulmonary dysplasia.

  2001cited by this paper
• Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn.

  2001cited by this paper
• Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia.

  2001cited by this paper
• Inhibition of angiogenesis decreases alveolarization in the developing rat lung.

  2000cited by this paper
• CLINICAL COURSE AND LUNG FUNCTION ABNORMALITIES DURING DEVELOPMENT OF NEONATAL CHRONIC LUNG DISEASE

  1999cited by this paper
• Atypical Chronic Lung Disease Patterns in Neonates

  1999cited by this paper
• Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia.

  1998cited by this paper
• Reduced gas transfer at rest and during exercise in school-age survivors of bronchopulmonary dysplasia.

  1998cited by this paper
• Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less.

  1996cited by this paper
• Diffusing capacity of the lung in school‐aged children born very preterm, with and without bronchopulmonary dysplasia

  1996cited by this paper
• Clinical Investigations: Nitric OxidePulsed Delivery of Inhaled Nitric Oxide to Patients With Primary Pulmonary Hypertension: An Ambulatory Delivery System and Initial Clinical Tests

  1996cited by this paper
• Hospitalization as a measure of morbidity among very low birth weight infants with chronic lung disease.

  1996cited by this paper
• Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.

  1995cited by this paper
• Pulmonary hypertension in infants with chronic lung disease: non-invasive evaluation and short term effect of oxygen treatment.

  1995cited by this paper
• Pulmonary and systemic arterial pressure in hyaline membrane disease.

  1992cited by this paper
• Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome.

  1992cited by this paper
• Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease

  1990cited by this paper
• Noninvasive estimation of systolic pressure in the right ventricle in patients with tricuspid regurgitation.

  1986cited by this paper
• Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound.

  1985cited by this paper
• Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients.

  1985cited by this paper
• Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.

  1984cited by this paper
• Pulmonary artery remodeling and pulmonary hypertension after exposure to hyperoxia for 7 days. A morphometric and hemodynamic study.

  1984cited by this paper
• Oxygen-Induced Alterations in Lung Vascular Development in the Newborn Rat

  1983cited by this paper
• Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn.

  1980cited by this paper
• Bronchopulmonary dysplasia: possible relationship to pulmonary edema.

  1978cited by this paper
• Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

  1967cited by this paper

• Follow-up of neonatal chronic respiratory disease: an update based on the current evidence

  2026cites this paper
• Utilization of integrated lung ultrasound and targeted neonatal echocardiography in preterm infant follow-up: is it feasible? Assessing value and practical challenges

  2026cites this paper
• Results of a pulmonary hypertension screening program for premature infants with bronchopulmonary dysplasia.

  2026cites this paper
• Clinical utility of echocardiography in bronchopulmonary dysplasia: a retrospective cohort study.

  2026cites this paper
• Characteristics associated with death or tracheostomy in infants with bronchopulmonary dysplasia following predominant non-invasive respiratory support

  2025cites this paper
• Chronic Lung Disease‐Related Pulmonary Hypertension in Children

  2025cites this paper
• Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series)

  2025cites this paper
• Sorted-Cell Proteomics Reveals an AT1-Associated Epithelial Cornification Phenotype and Suggests Endothelial Redox Imbalance in Human Bronchopulmonary Dysplasia.

  2025cites this paper
• Trends, Burden, and Inequality in Neonatal Pulmonary Arterial Hypertension: Global Estimates From 1990 to 2021

  2025cites this paper
• Development of late pulmonary hypertension after antenatal inflammation in experimental bronchopulmonary dysplasia

  2025cites this paper
• Caspase-8-driven NLRP3 inflammasome activation exacerbates bronchopulmonary dysplasia by increasing the apoptosis and pyroptosis crosstalk of alveolar epithelial cells.

  2025cites this paper
• Sorted-Cell Proteomics Reveals an AT1-Associated Epithelial Cornification Phenotype and Suggests Endothelial Redox Imbalance in Human Bronchopulmonary Dysplasia

  2025cites this paper
• Hospitalizations and outcomes in extremely premature infants with bronchopulmonary dysplasia and pulmonary hypertension at 5 years

  2025cites this paper
• Adrenomedullin Overexpression Protects Mice from Experimental Bronchopulmonary Dysplasia and Associated Pulmonary Hypertension.

  2025cites this paper
• Persistent Pulmonary Hypertension of the Newborn: A Pragmatic Review of Pathophysiology, Diagnosis, and Advances in Management

  2025cites this paper
• Airway Anomalies Predict Risk of Pediatric Pulmonary Hypertension

  2025cites this paper
• Impact of placental pathology on the risk of bronchopulmonary dysplasia in preterm infants: The role of gestational age and sex

  2025cites this paper
• Commonly used medications for respiratory and cardiovascular support in neonates: Evidence, knowledge gaps, and future perspectives

  2024cites this paper
• Inhaled Nitric Oxide Treatment of Early Pulmonary Hypertension to Reduce the Risk of Death or Bronchopulmonary Dysplasia in Infants Born Extremely Preterm: A Masked Randomized Controlled Trial.

  2024cites this paper
• Pulmonary hypertension in preterm neonates with bronchopulmonary dysplasia: a meta-analysis

  2024cites this paper
• Knockdown of the long noncoding RNA VSIG2-1:1 promotes the angiogenic ability of human pulmonary microvascular endothelial cells by activating the VEGF/PI3K/AKT pathway

  2024cites this paper
• Inhibition of lysophosphatidic acid receptor 2 attenuates neonatal chronic lung disease in mice by preserving vascular and alveolar development.

  2024cites this paper
• Biomarker screening for pulmonary hypertension in VLBW infants at risk for bronchopulmonary dysplasia

  2024cites this paper
• Clinical phenotype of pulmonary vascular disease requiring treatment in extremely preterm infants

  2024cites this paper
• Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: Basing Care on Physiology.

  2024cites this paper
• Navigating Diagnostic and Treatment Challenges of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia

  2024cites this paper
• Right ventricular function indices and platelet parameters for early prediction value of bronchopulmonary dysplasia: a retrospective study

  2024cites this paper
• Long-term impact of late pulmonary hypertension requiring medication in extremely preterm infants with severe bronchopulmonary dysplasia

  2024cites this paper
• Serial tissue Doppler imaging in the evaluation of bronchopulmonary dysplasia-associated pulmonary hypertension among extremely preterm infants: a prospective observational study

  2024cites this paper
• Bronchopulmonary Dysplasia in a Tertiary Level Neonatal Unit of North India: Risk Factors and Outcome: A Case-control Study

  2024cites this paper
• Assessing the role of tracheostomy placement in bronchopulmonary dysplasia with pulmonary hypertension

  2024cites this paper
• Pulmonary Hypertension in Established Bronchopulmonary Dysplasia: Physiologic Approaches to Clinical Care.

  2024cites this paper
• Pulmonary Vascular Phenotypes of Prematurity: The Path to Precision Medicine.

  2023cites this paper
• Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension—A pilot study

  2023cites this paper
• Current diagnosis and treatment practice for pulmonary hypertension in bronchopulmonary dysplasia—A survey study in Germany (PUsH BPD)

  2023cites this paper
• Pathogenesis and Physiologic Mechanisms of Neonatal Pulmonary Hypertension: Preclinical Studies.

  2023cites this paper
• Atrial septal defect closure is associated with improved clinical status in patients ≤ 10 kg with bronchopulmonary dysplasia

  2023cites this paper
• Respiratory management of established severe bronchopulmonary dysplasia.

  2023cites this paper
• Bronchopulmonary dysplasia - Associated pulmonary hypertension: An updated review.

  2023cites this paper
• MRI pulmonary artery flow detects lung vascular pathology in preterms with lung disease

  2023cites this paper
• Cardiopulmonary physiological effects of diuretic therapy in preterm infants with chronic pulmonary hypertension

  2023cites this paper
• Recent Advances in Pediatric Pulmonary Hypertension: Implications for Diagnosis and Treatment.

  2023cites this paper
• Clinical and Paraclinical Findings of Primary Pulmonary Hypertension in Children

  2023cites this paper
• Placing Ureaplasma within the Context of Bronchopulmonary Dysplasia Endotypes and Phenotypes

  2023cites this paper
• Location‐specific pathology analysis of the monopodial pulmonary vasculature in a rabbit model of bronchopulmonary dysplasia—A pilot study

  2023cites this paper
• The value of pulmonary artery acceleration time in evaluating pulmonary vascular disease in preterm infants with bronchopulmonary dysplasia

  2023cites this paper
• Overview of point-of-care ultrasound and functional echocardiography training programs in India

  2023cites this paper
• Respiratory support strategies in the management of severe, longstanding bronchopulmonary dysplasia

  2022cites this paper
• Hyperinflation and its association with successful transition to home ventilator devices in infants with chronic respiratory failure and severe bronchopulmonary dysplasia

  2022cites this paper
• Multi-omics endotype of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension

  2022cites this paper
• Respiratory Care for Neonates With Congenital Heart Disease.

  2022cites this paper
• Role of left atrial hypertension in pulmonary hypertension associated with bronchopulmonary dysplasia

  2022cites this paper
• Discharge Practices for Infants with Bronchopulmonary Dysplasia: A Survey of National Experts.

  2022cites this paper
• Mise au point sur la bronchodysplasie de l’ancien prématuré

  2022cites this paper
• 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

  2022cites this paper
• 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.

  2022cites this paper
• A prediction model of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia

  2022cites this paper
• Characteristics and outcome of infants with bronchopulmonary dysplasia established on long‐term ventilation from neonatal intensive care

  2022cites this paper
• Extremely premature infants born at 23–25 weeks gestation are at substantial risk for pulmonary hypertension

  2022cites this paper
• Pulmonary Vasodilator Therapy in Persistent Pulmonary Hypertension of the Newborn.

  2022influential citation
• Pulmonary hypertension in childhood

  2021cites this paper
• Pulmonary hypertension in the child with bronchopulmonary dysplasia

  2021cites this paper
• Association of the dysfunctional placentation endotype of prematurity with bronchopulmonary dysplasia: a systematic review, meta-analysis and meta-regression

  2021cites this paper
• Right Atrial Strain in Preterm Infants With a History of Bronchopulmonary Dysplasia

  2021cites this paper
• Imaging in neonatal respiratory disease.

  2021cites this paper
• Pulmonary hypertension in infants with bronchopulmonary dysplasia: risk factors, mortality and duration of hospitalisation

  2021cites this paper
• PH Professional Network: 360-degree Care for the Bronchopulmonary Dysplasia Infant with Pulmonary Hypertension: A Comprehensive Review

  2021cites this paper
• PH-ILD: Identification, Evaluation, and Monitoring: A Diagnostic View From Both Sides

  2021cites this paper
• Extracellular Vesicles Protect the Neonatal Lung from Hyperoxic Injury Through the Epigenetic and Transcriptomic Reprogramming of Myeloid Cells.

  2021cites this paper
• Bronchopulmonary dysplasia

  2021cites this paper
• Using pulmonary artery acceleration time to evaluate pulmonary hemodynamic changes on preterm infants with respiratory distress syndrome

  2021influential citation
• Pulmonary Function Tests in Very Low Birth Weight Infants Screened for Pulmonary Hypertension: A Pilot Study.

  2021cites this paper
• The Intertemporal Role of Respiratory Support in Improving Neonatal Outcomes: A Narrative Review

  2021cites this paper
• Right ventricular function and vasoactive peptides for early prediction of bronchopulmonary dysplasia

  2021cites this paper
• Short- and Long-Term Complications of Bronchopulmonary Dysplasia

  2021cites this paper
• DDAH1 SNP rs480414 that protects against the development of pulmonary hypertension in bronchopulmonary dysplasia results in lower nitric oxide production in neonatal cord blood-derived lymphoblastoid cell lines

  2021cites this paper
• Bibliometric Analysis of Bronchopulmonary Dysplasia in Extremely Premature Infants in the Web of Science Database Using CiteSpace Software

  2021cites this paper
• Long-term respiratory outcomes of BPD

  2021cites this paper
• Red cell distribution width as a predictor for bronchopulmonary dysplasia in premature infants

  2021cites this paper
• Bronchopulmonary Dysplasia and Pulmonary Hypertension: The Role of Smooth Muscle adh5.

  2021influential citation
• Early closure mechanisms of the ductus arteriosus in immature infants

  2021cites this paper
• Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia

  2020cites this paper
• Neonatal comorbidities and gasotransmitters.

  2020cites this paper
• Extracorporeal Life Support in Pediatric Patients with Bronchopulmonary Dysplasia and Associated Pulmonary Hypertension

  2020cites this paper
• Adrenomedullin Is Necessary to Resolve Hyperoxia-Induced Experimental Bronchopulmonary Dysplasia and Pulmonary Hypertension in Mice.

  2020influential citation
• Pulmonary Hypertension and Cardiac Changes in BPD

  2020cites this paper
• The expression of serum macrophage MIF and PLTP in neonatal bronchopulmonary dysplasia (BPD) and its values and significances in clinical diagnosis

  2020cites this paper
• Management of Severe BPD Requiring Chronic Medical Support

  2020cites this paper
• Ventilation Strategies in Severe Bronchopulmonary Dysplasia.

  2020cites this paper
• Tie-2 Cre-Mediated Deficiency of Extracellular Signal-Regulated Kinase 2 Potentiates Experimental Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Neonatal Mice

  2020cites this paper
• Pediatric Pulmonology 2019 year in review: Neonatal pulmonology

  2020cites this paper
• Novel Strategies to Reduce Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia

  2020cites this paper
• Present and Future of Bronchopulmonary Dysplasia

  2020cites this paper
• Phenotypes of Bronchopulmonary Dysplasia in Adults.

  2020cites this paper
• The Clinical Evaluation of Severe Bronchopulmonary Dysplasia.

  2020cites this paper
• Focused Update on Pulmonary Hypertension in Children—Selected Topics of Interest for the Adult Cardiologist

  2020cites this paper
• Phenotypes of Bronchopulmonary Dysplasia

  2020cites this paper
• How Do We Monitor Oxygenation During The Management of PPHN? Alveolar, Arterial or Mixed Oxygen Tension or Peripheral Saturation?

  2020cites this paper
• Recombinant adiponectin protects the newborn rat lung from lipopolysaccharide‐induced inflammatory injury

  2020cites this paper
• Interactive and Independent Effects of Early Lipopolysaccharide and Hyperoxia Exposure on Developing Murine Lungs.

  2020cites this paper